Table 3 ATC classification (1st level) of drugs used by patients with a recent history of depressive disorders
Drug class* | Total n (%) | Men n (%; 95% CI) | Women n (%; 95% CI) | 60Â years or older n (%; 95% CI) |
|---|---|---|---|---|
G | 703 (39.1) | 7 (1.3; 0.52, 2.68) | 696 (55.4; 51.4, 59.7) | 111 (22.3; 18.4, 26.9) |
C | 620 (34.4) | 150 (27.8; 23.6, 32.7) | 470 (37.4; 34.1, 41.0) | 247 (49.7; 43.7, 56.3) |
A | 562 (31.2) | 133 (24.7; 20.7, 29.2) | 429 (34.2; 31.0, 37.6) | 205 (41.3; 35.8, 47.3) |
N | 525 (29.1) | 157 (29.1; 24.8, 35.1) | 368 (29.3; 26.4, 32.5) | 142 (28.6; 24.1, 33.7) |
B | 510 (28.3) | 79 (14.7; 11.6, 18.3) | 431 (34.3; 31.2, 37.7) | 157 (31.6; 26.8, 36.9) |
M | 258 (14.3) | 50 (9.3; 6.9, 12.2) | 208 (16.6; 14.4, 19.0) | 119 (23.9; 19.9, 28.7) |
H | 238 (13.2) | 46 (8.5; 6.3, 11.4) | 192 (15.3; 13.2, 17.0) | 89 (17.9; 14.4, 22.0) |
R | 122 (6.8) | 31 (5.7; 3.9, 8.2) | 91 (7.3; 5.8, 8.9) | 41 (8.3; 5.9, 11.2) |
S | 20 (1.1) | 4 (0.7; 0.20, 1.9) | 16 (1.3; 0.7, 2.1) | 10 (2.0; 1.0, 3.7) |
L | 7 (0.4) | 2 (0.4; 0.04, 1.3) | 5 (0.4; 0.1, 0.9) | 2 (0.4; 0.1, 1.5) |